Achilles therapeutics to present at the 40th annual j.p. morgan healthcare conference

London, dec. 21, 2021 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced that iraj ali, chief executive officer, will present at the virtual 40th annual j.p. morgan healthcare conference on thursday, january 13, 2022, at 8:15 a.m. et.
ACHL Ratings Summary
ACHL Quant Ranking